ニコチン酸受容体は,古い薬の新しいメカニズムです
1Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK. Fredrik.Karpe@ocdem.ox.ac.uk
Lancet (London, England)
|June 9, 2004
まとめ
ニコチン酸は非エステル化された脂肪酸とVLDLトリグリセリドを低下させますが,逆説的にインスリン抵抗性を長期的に悪化させることがあります. その受容体メカニズムの理解は,代謝疾患に対する新しい治療法につながる可能性があります.
科学分野:
- メタボリック疾患の研究
- 薬理学 薬理学とは
- エンドクリノロジー エンドクリノロジー
背景:
- 血中の非エステル化脂肪酸 (NEFA) の増加は,インスリン抵抗性およびインスリン分泌の低下に寄与する.
- 肥満,特に上部脂肪の蓄積は,日中のNEFA濃度の上昇と関連しています.
- ニコチン酸は,NEFAとVLDLトリグリセリドを下げる主な薬ですが,インスリン抵抗性に対する長期的な影響は矛盾しています.
研究 の 目的:
- ニコチン酸の抗脂症効果の細胞メカニズムを調査する.
- ニコチン酸,コレステロールの動員,動脈動脈硬化症の逆行との関連を調査する.
- 脂肪酸代謝および関連する疾患の潜在的な治療標的を特定する.
主な方法:
- ニコチン酸の抗脂症効果の細胞メカニズムを調査した.
- ニコチン酸の独特のGタンパク質結合受容体に関する発見を活用した.
- ニコチン酸をマクロファージからコレステロールの動員に結びつける提案されたメカニズムを参考にした.
主要な成果:
- ニコチン酸の抗脂解作用のメカニズムは以前は知られていなかったが,Gタンパク質結合受容体と関連していた.
- ニコチン酸は,マクロファージからコレステロールの動員を刺激し,潜在的に動脈硬化症の逆行を助ける可能性があります.
- ニコチン酸によるインスリン感受性の短期的な改善は,リバウンド脂溶解による可能性のある長期的な悪化と対照的です.
結論:
- ニコチン酸受容体によるシグナル伝達の研究は,新たな治療戦略を提供している.
- 脂肪酸代謝をターゲットとする介入は,インスリン抵抗性,高脂血症,動脈硬化症に対処することができます.
- ニコチン酸受容体の理解は,これらの疾患に対するより効果的な治療法の開発の鍵です.
関連する概念動画
01:15Cholinergic Receptors: Nicotinic
6.5K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
6.5K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.7K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
01:25Cholinergic Receptors: Muscarinic
5.9K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.9K
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.5K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.5K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
3.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
3.0K